IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FGEN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in FibroGen stock price on Monday moving 10.48% between high and low
(Updated on Apr 15, 2024)

Sell candidate since Apr 03, 2024 Loss -10.88% PDF

The FibroGen stock price gained 0.769% on the last trading day (Monday, 15th Apr 2024), rising from $1.30 to $1.31. During the last trading day the stock fluctuated 10.48% from a day low at $1.24 to a day high of $1.37. The price has fallen in 6 of the last 10 days and is down by -44.49% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 99 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $1.61 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.31 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 22.98% during the next 3 months and, with a 90% probability hold a price between $1.61 and $3.87 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

FGEN Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The FibroGen stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.45 and $1.95. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 09, 2024, and so far it has fallen -52.01%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for FibroGen stock

FibroGen finds support from accumulated volume at $1.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.130 between high and low, or 10.48%. For the last week, the stock has had daily average volatility of 9.83%.

FibroGen is oversold on RSI14 (16). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FGEN) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect FibroGen to open at $1.31, and during the day (based on 14 day Average True Range), to move between $1.05 and $1.57, which gives a possible trading interval of +/-$0.256 (+/-19.57%) up or down from last closing price. If FibroGen takes out the full calculated possible swing range there will be an estimated 39.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.30 (0.76%) than the resistance at $1.47 (12.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is FibroGen stock A Buy?

The FibroGen stock holds several negative signals and despite the positive trend, we believe FibroGen will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.315 Strong Sell Candidate Downgraded

Predicted Opening Price for FibroGen of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$1.31 ( 0.254%) $1.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FGEN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.44 9.67 %
R2 1.39 5.88 %
R1 1.36 3.54 %
Current price: 1.31
Support S1 1.26 -4.05 %
S2 1.23 -6.39 %
S3 1.18 -10.18 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.62 23.66 %
R2 1.58 20.61 %
R1 1.47 12.21 %
Current price 1.31
Support S1 1.30 -0.763%
S2 1.10 -16.03%
S3 0 .

FAQ

What is the symbol for FibroGen Stock and on which exchange is it traded?
The symbol for FibroGen is FGEN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell FibroGen Stock?
The FibroGen stock holds several negative signals and despite the positive trend, we believe FibroGen will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy FibroGen Stock?
FibroGen Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy FibroGen Stock.

What's the current price of FibroGen Stock?
As of the end of day on the 2024-04-15, the price of an FibroGen (FGEN) share was $1.31.

What is the 52-week high and low for FibroGen Stock?
The 52-week high for FibroGen Stock is $20.90 and the 52-week low is $0.335.

What is the market capitalization of FibroGen Stock?
As of the 2024-04-15, the market capitalization of FibroGen is 129.39M.

When is the next earnings date for FibroGen?
The upcoming earnings date for FibroGen is May 13, 2024.
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT